| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 03/21/2013 | WO2012118409A3 Spirocyclic cyclopropanoic amino acids and drugs based thereon |
| 03/21/2013 | US20130072704 Dispersant composition |
| 03/21/2013 | US20130072703 Dispersant composition |
| 03/21/2013 | US20130071439 Methods and compositions for treating biofilms |
| 03/21/2013 | US20130071327 Homoglutamic acid derivatives |
| 03/20/2013 | EP2569277A1 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof |
| 03/20/2013 | EP2569276A1 Novel cationic lipids and methods of use thereof |
| 03/20/2013 | EP2569275A1 A process for the hydrogenation of ketoesters |
| 03/20/2013 | CN102985399A Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group |
| 03/20/2013 | CN102978250A Method for producing Gamma-aminobutyric acid through centrifugal mother liquid of glutamic acid |
| 03/20/2013 | CN102976964A Dehydroabietic acid triarylamine compound as well as preparation method and application thereof |
| 03/20/2013 | CN102976963A Method for extraction of L-phenylalanine |
| 03/20/2013 | CN102976962A L-ornithine-aspirin double salt and its preparation method and use |
| 03/20/2013 | CN101602681B Method for preparing derivatives of beta-enaminone and ester |
| 03/20/2013 | CN101519360B Method for preparing iminodiacetic acid |
| 03/20/2013 | CN101243043B Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 03/19/2013 | US8399705 Alkali metal salt of glutamic acid N,N-diacetic acid, a process to prepare such salt, and the use thereof |
| 03/19/2013 | US8399662 O-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 03/19/2013 | US8399518 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome |
| 03/19/2013 | US8399517 Calcilytic compounds |
| 03/19/2013 | US8399513 Levodopa prodrug mesylate hydrate |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/14/2013 | US20130065962 Compounds For Use In The Treatment Of Diseases |
| 03/14/2013 | US20130065957 Diclofenac salt of tramadol |
| 03/14/2013 | US20130064893 Stabilized pharmaceutical composition |
| 03/13/2013 | EP2566842A1 Process for preparing saturated amino acids or saturated amino esters comprising a metathesis step |
| 03/13/2013 | CN1938244B Fluoridation method |
| 03/13/2013 | CN102971285A A process for the production of carnitine |
| 03/13/2013 | CN102964261A Preparation method of ornithine aspartate |
| 03/13/2013 | CN102964260A Preparation method of N,N-dimethyl-N-fatty alcohol polyethenoxy ether-base carboxymethyl lycine |
| 03/13/2013 | CN102964194A Rh3Ni1 catalyst and method for preparing arylamine by carrying out catalytic reduction on nitro aromatic hydrocarbon through Rh3Ni1 catalyst |
| 03/13/2013 | CN102060723B Preparation method of cationic liposome nanoparticles of amino acid |
| 03/13/2013 | CN102050720B Novel DHA derivative and its usage as medicine |
| 03/13/2013 | CN102020577B Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 03/13/2013 | CN101838212B Method for synthesizing L-carnitine by using (R)-(-)-3-chlorine-1,2-propylene glycol as chiral initiative raw material |
| 03/13/2013 | CN101735086B Desalting purifying method in L-carnitine production |
| 03/13/2013 | CN101563329B Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione) |
| 03/13/2013 | CN101434572B Prodrugs of GABA analogs, compositions and uses thereof |
| 03/12/2013 | US8394970 Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof |
| 03/12/2013 | US8394853 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 03/12/2013 | US8394288 Use of solid betaine product and method for its manufacture |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2660348C A novel process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester |
| 03/07/2013 | WO2013030792A1 Insecticidal lipid agents isolated from entomopathogenic fungi and uses thereof |
| 03/07/2013 | WO2013030654A1 Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof |
| 03/07/2013 | WO2013030481A1 Process for the synthesis of c11 and c12 omega-aminoalkanoic acid esters comprising a nitrilaton step |
| 03/07/2013 | WO2013030358A1 Glycine b antagonists |
| 03/07/2013 | WO2013029555A1 Lavendustin a derivatives, preparation method and use thereof |
| 03/07/2013 | US20130060028 Novel processes |
| 03/07/2013 | US20130059913 Composition for amelioration of hypoalbuminemia |
| 03/07/2013 | US20130058990 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent |
| 03/07/2013 | CA2847291A1 Insecticidal lipid agents isolated from entomopathogenic fungi and uses thereof |
| 03/07/2013 | CA2847285A1 Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof |
| 03/06/2013 | CN102959461A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| 03/06/2013 | CN102958910A Beta-aminocarbonyl compound production method |
| 03/06/2013 | CN102958892A Method for preparing chemical compounds of interest by aromatic nucleophilic substitution |
| 03/06/2013 | CN102952161A Chromium-containing amorphous coordination polymer particle and preparation method thereof |
| 03/06/2013 | CN102952031A Novel reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor, process cartridge, and image forming apparatus |
| 03/06/2013 | CN102952030A Compound, charge transporting film, photoelectric conversion device, and electrophotographic photoreceptor |
| 03/06/2013 | CN102952029A Reagent and method for resolving 2-hydroxyl-3-methoxy-3,3-diphenyl propionic acid racemate |
| 03/06/2013 | CN102952028A Preparation method of L-carnitine and its intermediate |
| 03/06/2013 | CN102951979A Preparation method of 2-substitutional vinyl alcohol formate derivative |
| 03/06/2013 | CN101914043B Method for synchronously extracting and preparing taurine, biological zinc and polypeptide from oysters |
| 03/06/2013 | CN101654410B Processes for preparing bicyclo (3.1.0) hexane derivatives, and intermediates thereto |
| 03/05/2013 | US8389772 Aldehydes containing hydroxl groups |
| 03/05/2013 | US8389769 Polymerizable type II photoinitiators and curable compositions |
| 03/05/2013 | US8389657 Poly(meth)acrylamides and poly(meth)acrylates containing flourinated amide |
| 02/28/2013 | WO2013026940A1 Simplified radiosynthesis of o-[18f]fluoromethyl tyrosine derivatives |
| 02/28/2013 | US20130052585 Photodecomposable bases and photoresist compositions |
| 02/28/2013 | US20130052571 Novel compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor, process cartridge, and image forming apparatus |
| 02/28/2013 | CA2846260A1 Simplified radiosynthesis of o-[18f]fluoromethyl tyrosine derivatives |
| 02/27/2013 | EP2560948A1 Radiation curable amino(meth)acrylates |
| 02/27/2013 | EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 02/27/2013 | CN102946962A Separation process |
| 02/27/2013 | CN102946961A Separation process |
| 02/27/2013 | CN102942589A Salts of isophosphoramide mustard and analogs thereof |
| 02/27/2013 | CN102942499A Preparation method of asphalt release agent |
| 02/27/2013 | CN102942498A Ornithine aspartate compound and preparation method thereof |
| 02/27/2013 | CN102942497A Preparation and application of amino substituted carboxylic acid compounds |
| 02/27/2013 | CN102942482A Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 02/27/2013 | CN101759580B Method for preparing threonine crystal by threonine fermentation liquid |
| 02/27/2013 | CN101735088B Production process of glutamic acid and monosodium glutamate |
| 02/27/2013 | CN101417959B Synthesis method of L-p-nitrophenylalanine |
| 02/26/2013 | US8383853 Method for preparing 2,6-diethyl-4-methylphenylacetic acid |
| 02/26/2013 | US8383547 Aflatoxin production inhibitor and method for controlling aflatoxin contamination using the same |
| 02/21/2013 | US20130046017 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/20/2013 | CN102936536A Intergrated chemical processe for industrial utilization of seed oils |
| 02/20/2013 | CN102936206A Quick-breaking and quick-curing type asphalt emulsifier preparation method |
| 02/20/2013 | CN102936182A Vanadium-doped porous titanium dioxide nitro solid phase reducing agent rich in activated hydrogen and preparation method and application thereof |
| 02/20/2013 | CN102935333A Method for separating glutamic acid and lactic acid from fermentation waste liquor by packed bed electrodialysis |
| 02/20/2013 | CN101898975B Synthesis method of S-O-chlorobenzene glycine methyl ester tartrate |
| 02/20/2013 | CN101838213B Method for preparing laminine and pharmaceutically acceptable salts thereof |
| 02/20/2013 | CN101747222B Glycine chelate oyster calcium aqueous synthesis method and preparation of high-calcium soy |
| 02/19/2013 | US8377986 Amino acid derivatives |
| 02/19/2013 | US8377661 Method for synthesising omega-amino-alkanoic acids or the esters thereof from natural fatty acids |
| 02/19/2013 | US8377478 Solid detergent composition |
| 02/14/2013 | WO2012012278A3 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 02/14/2013 | US20130041176 Structure assessment of heterogeneous polypeptide mixture |
| 02/14/2013 | US20130041156 Azapeptide derivatives |